Lv1
80 积分 2022-08-30 加入
Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma
1个月前
已完结
ABCL-802: ARV-393, a PROTAC BCL6 Degrader, in Preclinical Models of Diffuse Large B-cell Lymphoma (DLBCL), Nodal T-Follicular Helper Cell Lymphoma (nTFHL), and Transformed Follicular Lymphoma (tFL)
1个月前
已关闭
The Expression of Bcl-6 In Diffuse Large B Cell Lymphoma (DLBCL) Is Associated with Improved Progression Free Survival and Overall Survival Following Front-Line Rituximab-Chemotherapy
1个月前
已关闭
B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas
1个月前
已完结
UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis
7个月前
已完结
皖公网安备34019202002308
